Positive results from immunogenicity testing send Prescient’s shares higher
In an upbeat development, Prescient Therapeutics Limited (ASX:PTX) has announced outstanding findings from in silico...
In an upbeat development, Prescient Therapeutics Limited (ASX:PTX) has announced outstanding findings from in silico...
Shares in Prescient Therapeutics Ltd (ASX: PTX) have surged to fresh heights today on the back of news...
Prescient Therapeutics (PTX) says recent results from testing show its entire platform has been substantially...
The results significantly de-risk the project as PTX continues development of its OmniCAR platform. As...
Tragedy struck the CAR-T space this month with a US company halting a trial of...
In a milestone development regarding its innovative CAR-T cancer therapy programs, Prescient Therapeutics Limited (ASX:PTX) has announced...
Clinical stage oncology company Prescient Therapeutics (ASX:PTX) has announced another crucial step forward in the development of...
Prescient Therapeutics (PTX) has slipped on the ASX today despite announcing some key developments for...
The terrible news this week that Tmunity Therapeutics, a clinical stage biotherapeutics company, has halted...
Australia’s medical community has welcomed a new ‘patent box’ tax regime designed to encourage further...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.